Search company, investor...

Cangene

Founded Year

1984

Stage

Acq - P2P | Acquired

Valuation

$0000 

About Cangene

Cangene is a biotech company based in Rockville, Maryland.

Headquarters Location

Rockville, Maryland,

United States

Missing: Cangene's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cangene's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cangene Patents

Cangene has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/31/2016

6/12/2018

Monoclonal antibodies, Transcription factors, Immunology, Immune system, EC 2.4.1

Grant

Application Date

10/31/2016

Grant Date

6/12/2018

Title

Related Topics

Monoclonal antibodies, Transcription factors, Immunology, Immune system, EC 2.4.1

Status

Grant

Latest Cangene News

Bleeding Disorders Treatment Market Report – Know the Latest Innovations and Trends to 2029

Feb 7, 2022

Bleeding Disorders Treatment Market Report – Know the Latest Innovations and Trends to 2029 The new report on Sales Analysis of Bleeding Disorders Treatment market is a comprehensive study providing analysis on factors trend and drivers contributing to demand of Bleeding Disorders Treatment Market Growth, Estimation of contribution of segment is expressed in terms of volume and revenue for the forecast period 2022-2029. The report conveys pin point investigation of key market segments, market share, specific geographical regions, key market players, and trends in vital industries. It illustrates the potential opportunities and challenges of the market in each region. The research report highlights the market by various segments such as type, application, end-users, and region. It also analyzes the market majors to evaluate the degree of competition in the industry vertical. Moreover, it also analyses and compares the market status and forecast between major regions, namely, US, Europe, China, Japan, India, Southeast Asia, and Rest of world. Providing business leaders with insights on Bleeding Disorders Treatment industry and how they can increase their market share. Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bleeding-disorders-treatment-market Bleeding Disorders Treatment Market: Competition Landscape Takeda Pharmaceutical Company Limited., Pfizer Inc., Biogen, CSL, Bayer AG, Grifols, S.A., Sun Pharmaceutical Industries Ltd., Octapharma AG, Ferring B.V., Novo Nordisk A/S, Alnylam Pharmaceuticals, Inc., Xenetic Biosciences, Inc., Bristol-Myers Squibb Company, Sanofi, Janssen Pharmaceuticals, Inc., Amgen Inc., Cangene Corporation, BD, Bosch Healthcare Solutions GmbH, Baxter and Novartis AG Global Bleeding Disorders Treatment Market Taxonomy By Drug Type (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants and Others) By Disease type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Liver Disease and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Compounding Pharmacies) By End Users (Clinics, Hospitals and Academic Institutions) Covid-19 Impact on the Bleeding Disorders Treatment Market The impact of the coronavirus pandemic and the subsequent establishment of nationwide lockdowns is visible in various industries. The overall growth of various sectors has been heavily impacted, especially in countries with a high incidence rate of COVID-19, such as India, China, Brazil, the US, and several European countries (including Russia, Italy, and Spain). While industries such as oil and petroleum, aeronautics, and mining are experiencing a steep fall in revenues, the healthcare, biotechnology, and pharmaceutical industries are optimizing this situation to serve a maximum number of patients and healthcare professionals. The Growth in this Bleeding Disorders Treatment market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in Bleeding Disorders Treatment industry. On the other hand, a lack of awareness and access to Bleeding Disorders Treatment programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market. Promising Regions & Countries Mentioned in The Bleeding Disorders Treatment Report: North America (United States) QUERIES SOLVED: Study Explore COVID 19 Outbreak Impact Analysis What is the size of the overall Bleeding Disorders Treatment Market and challenges to the market in the growth of the Healthcare Industry? What are the key drivers, restraints, opportunities, and challenges of the market in the Healthcare Industry, and how they are expected to impact the market? What are the key segments and sub-segments in the market? What is market chain analysis by upstream raw materials and downstream industry? What is industry considering capacity, production and production value? What are the strategies for growth adopted by the key players in Bleeding Disorders Treatment Market? What will be market share, supply and consumption? What is the market in the Industry size at the regional and country-level? What were capacity, production value, cost and profit? Who are the key players in this industry? What are their company profile, their product information, and contact information? What are the recent trends in Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)? This detailed report estimates the growth rate and the Bleeding Disorders Treatment market utility based on major fragments such as types, applications, sectors. The complete report highlights the latest industrial updates, market possibilities, and upcoming trends. Bleeding Disorders Treatment market research report has gone through the proper research methodology and is validated from the professionals and analysts to ensure the eminent quality reports before presenting it to the users as well as detailed product and service-based innovations are also thoroughly discussed in this report. Our organization covers all the key points required for your research study. The Bleeding Disorders Treatment market research includes historical and forecasts market data, demand, price, trends, and company shares by geography. The report, therefore, presents a tour of the thriving market scenario, demand and supply analysis, and technological milestones. To Get Detailed Table Of Content (Toc), Please Click –  https://www.databridgemarketresearch.com/toc/?dbmr=global-bleeding-disorders-treatment-market Analyzing the Investment Potential of the Global Bleeding Disorders Treatment Market Report The Global Bleeding Disorders Treatment Market covers across the past and current dynamics to deduce significant developments in the afore mentioned market, thus effectively encouraging agile business outcome The report also is a ready-to-refer documentation that entails substantial information featuring the developments across segments and their role in growth optimization. Research analysts leverage their years of experience and expertise to create perfect and error-free Bleeding Disorders Treatment market report. The report also ensures investor participation towards directing manufacturer and vendor activities in a bid to achieve significant competitive edge. The core values such as trust, integrity, and authenticity have been kept at the centre while delivering this report to the client. Market based developments are also accurately sectioned in both value-based volume-based calculations to thoroughly encourage reader understanding and subsequent growth potential in market. Make An Enquiry and Ask For Customized Report@  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bleeding-disorders-treatment-market After reading the Market insights of Bleeding Disorders Treatment Report, readers can: Understand the drivers, restraints, opportunities, growth opportunities and trends affecting the Sales of market. Analyze key regions holding significant share of total Bleeding Disorders Treatment market revenue and dynamic segments Study the growth outlook of Bleeding Disorders Treatment market scenario, including production, consumption, history and forecast. Learn consumption pattern and impact of each end use & supply side analysis of Bleeding Disorders Treatment market. Investigate the recent R&D projects performed by each market player & competition spectrum and winning strategies of the major players. About Data Bridge Market Research Private Ltd: Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market. Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.” Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Contact Us                                                          UK: +44 208 089 1725 Hong Kong: +852 8192 7475

Cangene Frequently Asked Questions (FAQ)

  • When was Cangene founded?

    Cangene was founded in 1984.

  • Where is Cangene's headquarters?

    Cangene's headquarters is located at Rockville.

  • What is Cangene's latest funding round?

    Cangene's latest funding round is Acq - P2P.

  • Who are the investors of Cangene?

    Investors of Cangene include Emergent BioSolutions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.